| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/26/2012 | CN102688268A Method for ultrasonic extraction and content determination for total gambogic acid in gamboge medicinal materials |
| 09/26/2012 | CN102688267A Preparation method for antineoplastic preparation of total gambogic acid |
| 09/26/2012 | CN102688266A Method for separating and purifying Chinese actinidia root flavone by simulated moving bed chromatography |
| 09/26/2012 | CN102688264A New use of Primula sikkmensis Hook or extract thereof |
| 09/26/2012 | CN102688250A Synthesis and application of azo derivatives as inhibitor of RSK2 |
| 09/26/2012 | CN102688248A Use of bufadienolide compound in preparing medicines for treating oral mucosal malignant tumors |
| 09/26/2012 | CN102688246A Phlomis umbrosa root total-drop triterpene composition and extraction method and application thereof |
| 09/26/2012 | CN102688240A Pharmaceutical composition for treating colorectal cancer |
| 09/26/2012 | CN102688234A Synthesis of indolone derivative as RSK2 inhibitor and application |
| 09/26/2012 | CN102688233A Synthesis of benzotriazol derivative as RSK2 inhibitor and application thereof |
| 09/26/2012 | CN102688232A Synthesis and application of isoindole-1, 3-dione derivative as RSK2 inhibitor |
| 09/26/2012 | CN102688228A Pharmaceutical composition containing apigenin, apigenin derivative, rubescensin and rubescensin derivative, and application thereof |
| 09/26/2012 | CN102688223A Anti-cancer drug-loading nanofiber film and preparation method thereof |
| 09/26/2012 | CN102688219A Sulforaphane microencapsulation method |
| 09/26/2012 | CN102688202A Temozolomide freeze-dried preparation |
| 09/26/2012 | CN102688200A Plant anti-cancer targeting nano-preparation, and preparation method thereof |
| 09/26/2012 | CN102688199A Decitabine lyophilized preparation and preparation method thereof |
| 09/26/2012 | CN102688195A Preparation method for doxorubicin hydrochloride-entrapped chitosan carboxymethyl chitosan nanometer controlled-release particle with pH sensibility |
| 09/26/2012 | CN102688193A Temperature-sensitive liposome preparation of vinblastine medicament and preparation method thereof |
| 09/26/2012 | CN102688191A Medicine composition containing vitamin K1 and oil |
| 09/26/2012 | CN102391352B Amino acid derivatives of rotundic acid and application of derivatives in preparation of antitumor medicines |
| 09/26/2012 | CN102302733B Oral Chinese medicinal composition for treating ovarian cyst |
| 09/26/2012 | CN102228515B Separation and enrichment method of total flavones and total alkaloids of Lotus Plumule |
| 09/26/2012 | CN102228452B Honokiol or magnolol or honokiol-magnolol mixed solid lipid nanosphere preparation and preparation method thereof |
| 09/26/2012 | CN102219865B Preparation method of cherokee rose polysaccharide derivatives with antitumor activity |
| 09/26/2012 | CN102218069B Applicationof A-nor-5 alpha-androstane compounds in preparation of malignant tumor resistant medicaments |
| 09/26/2012 | CN102178651B Tretinoin fat emulsion injection and preparation method thereof |
| 09/26/2012 | CN102160867B Application of astragaloside II in preparing anti-cancer medicines |
| 09/26/2012 | CN102145178B PEG interleukin 15 |
| 09/26/2012 | CN102125569B Application of 1, 6-bisphosphate fructose in preparation of anti-cancer medicaments |
| 09/26/2012 | CN102114013B Compound inhibiting angiogenesis and preparation method and application thereof |
| 09/26/2012 | CN102091100B Method for improving main medicinal ingredients through solid fermentation of Indian buead and cordyceps militaris |
| 09/26/2012 | CN102018690B Anti-tumor medicament and application thereof |
| 09/26/2012 | CN101991601B Method for preparing uroacitide composition |
| 09/26/2012 | CN101962400B Linear epitope minimum motif peptide of human papilloma virus type 58 L1 protein and application thereof |
| 09/26/2012 | CN101903029B Combination therapy with organic arsenicals |
| 09/26/2012 | CN101886090B Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof |
| 09/26/2012 | CN101879305B Application of serum thymic factors to preparation of anti-tumor medicine and protection medicine of tumor physical and chemical treatment medicine |
| 09/26/2012 | CN101816702B Lung cancer preventing and treating composition extracted from selfheal and/or garden orache and application thereof in preparation of lung cancer preventing and treating medicine |
| 09/26/2012 | CN101747437B Apoptin-EC-SOD carboxyl terminal protein transduction domain fusion protein |
| 09/26/2012 | CN101735217B Application of imidazole [4,5-f][1,10] phenanthroline and derivative thereof to preparation of antineoplastic drug |
| 09/26/2012 | CN101712711B Sterol from sponge, preparation method and application thereof |
| 09/26/2012 | CN101691384B Phosphate-containing toluylene compound, preparation method thereof and use thereof |
| 09/26/2012 | CN101624413B Chalcomycin compounds and preparation and application of same |
| 09/26/2012 | CN101575607B Recombinant BCG vaccine based on human MUC1 repetitive sequence and GM-CSF fusion expression |
| 09/26/2012 | CN101420943B Chewing composition containing coenzyme q10 |
| 09/26/2012 | CN101186650B Antibody against secreted N-terminal peptide or C-terminal peptide of GPC3 present in blood |
| 09/26/2012 | CN101128484B Compositions and methods relating to anti IGF-1 receptor antibodies |
| 09/26/2012 | CN101119743B Immunopotentiating agent |
| 09/26/2012 | CN101086007B Manyzoned polypore glycopeptide production method and formulation thereof |
| 09/26/2012 | CN101072792B Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal |
| 09/25/2012 | US8273916 Crystal comprising (2R)-2-propyloctanoic acid and amine |
| 09/25/2012 | US8273870 Compositions and methods for inhibiting expression of a mutant gene |
| 09/25/2012 | US8273868 Compositions and methods for inhibiting viral replication |
| 09/25/2012 | US8273765 Bicyclo-pyrazoles and pharmaceutical compositions comprising them |
| 09/25/2012 | US8273756 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 09/25/2012 | US8273755 4-methylpyridopyrimidinone compounds |
| 09/25/2012 | US8273742 Disubstituted phthalazine hedgehog pathway antagonists |
| 09/25/2012 | US8273741 Imidazo-pyridazinyl compounds and uses thereof |
| 09/25/2012 | US8273724 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 09/25/2012 | US8273716 Use of LHRH antagonists for intermittent treatments |
| 09/25/2012 | US8273379 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 09/25/2012 | US8273353 Inhibitors of vascular endothelial growth factor activity |
| 09/25/2012 | US8273349 Binding member which binds to both lewis-Y and lewis-B haptens, and its use for treating cancer |
| 09/25/2012 | US8273344 Plasmid construct comprising cytochrome p450 oxygenase inhibitory oligonucleotides for use in prevention and treatment of cell proliferative disorders |
| 09/25/2012 | CA2664137C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 09/25/2012 | CA2648109C Combination of an anti-ed-b fibronectin domain antibody-il-2 fusion protein and gemcitabine |
| 09/25/2012 | CA2641744C Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors |
| 09/25/2012 | CA2522994C Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer |
| 09/25/2012 | CA2516822C Method for preparing acid addition salts of polyacidic basic compound |
| 09/25/2012 | CA2496688C Glycinamide derivatives as raf-kinase inhibitors |
| 09/25/2012 | CA2453295C Novel oligoribonucleotide derivatives for specific inhibition of gene expression |
| 09/25/2012 | CA2428438C Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 09/25/2012 | CA2323681C Development of human monoclonal antibodies and uses thereof |
| 09/25/2012 | CA2229171C Method of modulating gene expression with reduced immunostimulatory response |
| 09/20/2012 | WO2012126013A2 Method for making pluripotent stem cells |
| 09/20/2012 | WO2012125998A1 Yeast-brachyury immunotherapeutic compositions |
| 09/20/2012 | WO2012125981A2 Raf kinase inhibitors |
| 09/20/2012 | WO2012125828A2 Methods of treating breast cancer with anthracycline therapy |
| 09/20/2012 | WO2012125791A2 Incorporation of the b18r gene to enhance antitumor effect of virotherapy |
| 09/20/2012 | WO2012125787A1 METHODS FOR TREATING LEUKEMIA AND DISORDERS MEDIATED BY CBFβ AND RUNX1 PROTEINS |
| 09/20/2012 | WO2012125623A2 Cleavage inhibitors of transforming growth factor beta type i receptor and uses thereof in cancer therapy |
| 09/20/2012 | WO2012125510A1 Combination therapies for hematologic malignancies |
| 09/20/2012 | WO2012125487A1 Compositions, methods and uses for radioprotectants |
| 09/20/2012 | WO2012125459A1 Methods of treating cancer using 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione |
| 09/20/2012 | WO2012125447A2 Piperazinedione compounds |
| 09/20/2012 | WO2012125438A1 Solid forms of 3-(5-amino-2methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses |
| 09/20/2012 | WO2012125405A2 Methods and materials for assessing responsiveness to lenalidomide, thalidomide, and/or other thalidomide analogs |
| 09/20/2012 | WO2012125124A1 Fgfr1 antibodies and treatment of cancer |
| 09/20/2012 | WO2012125014A1 A plant-based cancer chemopreventive agent |
| 09/20/2012 | WO2012124858A1 Pharmaceutical composition with enhanced efficacy for inhibiting angiogenesis |
| 09/20/2012 | WO2012124641A1 Activity enhancer for anticancer agent |
| 09/20/2012 | WO2012124334A1 Antibody, pharmaceutical composition used for treatment of breast cancer, tumor test method, and reagent for testing tumor |
| 09/20/2012 | WO2012123823A1 Combination of anti-clusterin oligonucleotide with hsp90 inhibitor for the treatment of prostate cancer |
| 09/20/2012 | WO2012123820A1 Combination of anti-clusterin oligonucleotide with androgen receptor antagonist for the treatment of prostate cancer |
| 09/20/2012 | WO2012123745A1 Pyrrolopyridineamino derivatives as mps1 inhibitors |
| 09/20/2012 | WO2012123522A1 6,5-heterocyclic propargylic alcohol compounds and uses therefor |
| 09/20/2012 | WO2012123504A1 Compositions and methods for inhibiting tumor development caused by chemotherapy induced senescence |
| 09/20/2012 | WO2012123470A1 Imidazo pyrazines |
| 09/20/2012 | WO2012123423A1 N-carboxyalkyl-auristatins and use thereof |